Immediate and long-term effects of COVID-19 on antibiotic dispensing: increasing use of Watch antibiotics
Open Access
- 30 April 2024
- journal article
- research article
- Published by Journal of Infection in Developing Countries in The Journal of Infection in Developing Countries
- Vol. 18 (04) , 504-512
Abstract
Introduction: The coronavirus disease 2019 (COVID-19) pandemic affected antibiotic usage worldwide. However, there is limited data from Serbia. Dispensing of oral antibiotics in Serbian pharmacies was analyzed to calculate monthly and yearly changes between 2018-2021, and to explore immediate and long-term effects of COVID-19 on antibiotic dispensing during this period. Methodology: The number of antibiotic packages dispensed from pharmacies during the study period was analyzed with a Chi-square test to assess the average change in annual dispensing, and an interrupted time-series analysis was used to evaluate the impact of the pandemic on antibiotic dispensing. The data from 2018-2021 were retrieved from the database of a large community pharmacy chain in Serbia. Results: The average number of antibiotic packages dispensed per day and per pharmacy was higher in 2021 compared to 2018 by one package. However, the dispensing of macrolides increased significantly; 17.7% (2018) vs. 22.5% (2021) (p < 0.05). In general, an increase in antibiotic dispensing was detected during COVID-19 for total antibiotics (16.4%), Watch antibiotics (44.8%), third-generation cephalosporins (80.4%), macrolides (45.5%) and azithromycin (83.7%). However, the immediate effect of COVID-19 was a decrease in the dispensing of Watch antibiotics, penicillin, and third-generation cephalosporins (p < 0.05); and a notable long-term COVID-19 effect was an increase in the dispensing of azithromycin (p < 0.05). Conclusions: In spite of a relatively stable trend of total antibiotic dispensing before and during COVID-19 pandemic, the use of Watch antibiotics, third-generation cephalosporins, and macrolides (particularly azithromycin) showed an increasing trend in dispensing that should be optimized.Keywords
Funding Information
- Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja (451-03-47/2023-01/ 200161)
This publication has 30 references indexed in Scilit:
- Comparison of drug prescribing before and during the COVID‐19 pandemic: A cross‐national European studyPharmacoepidemiology and Drug Safety, 2022
- Antimicrobial Use Fell Substantially in Japan in 2020—The COVID-19 Pandemic May Have Played a RoleInternational Journal of Infectious Diseases, 2022
- Efficacy and safety of azithromycin in Covid‐19 patients: A systematic review and meta‐analysis of randomized clinical trialsReviews in Medical Virology, 2021
- Summary of adverse drug events for hydroxychloroquine, azithromycin, and chloroquine during the COVID-19 pandemicJournal of the American Pharmacists Association, 2021
- COVID-19: Clouds Over the Antimicrobial Resistance LandscapeArchives of Medical Research, 2021
- Macrolides and viral infections: focus on azithromycin in COVID-19 pathologyInternational Journal of Antimicrobial Agents, 2020
- RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trialInternational Journal of Antimicrobial Agents, 2020
- Self-medication with antibiotics in Serbian households: a case for action?International Journal of Clinical Pharmacy, 2017
- Home pharmacies in Serbia: an insight into self-medication practiceInternational Journal of Clinical Pharmacy, 2015
- Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseasesEuropean Journal of Clinical Pharmacology, 2011